Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
![PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model](https://i1.rgstatic.net/publication/309957914_Hemolytic_anemia_repressed_hepcidin_level_without_hepatocyte_iron_overload_Lesson_from_Gunther_disease_model/links/5e1ee05692851c3cbe657577/largepreview.png "PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model")
PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness | Haematologica
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the Europ
Sickle cell disease is a global prototype for integrative research and healthcare - Royal - 2021 - Advanced Genetics - Wiley Online Library
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
Untitled
Haematologica, Volume 102, issue 12 by Haematologica - Issuu
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Haematologica, Volume 106, Issue 5 by Haematologica - Issuu
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsiv
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
PDF) Pregnancy outcome in patients with -thalassemia intermedia at two tertiary care centers, in Beirut and Milan | Mohammed Naja - Academia.edu
Haematologica Atlas of Hematologic Cytology
Haematologica, Volume 105, Issue 7 by Haematologica - Issuu
PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy
Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
